Background Increasing reports suggest the safe use of direct oral anticoagulants (DOACs) in
electrical cardioversion. The aim of this study was to assess the trends and 30-day outcomes …

Background For some patients with atrial fibrillation, direct current cardioversion (DCCV) is
one strategy that can be used to establish sinus rhythm but appropriate anticoagulation is …

Methods Retrospective cohort study including all patients booked for elective DCCV at a
tertiary care center between January 2012-February 2015. Patients with non-valvular AF or …

Background A systematic evaluation focused on efficacy and safety for electrical
cardioversion of atrial fibrillation (AF) among different Direct Oral Anticoagulants (DOACs) …

Abstract Background Direct oral anticoagulants (DOACs) have emerged as the preferred
choice of oral anticoagulation in patients with atrial fibrillation. Randomized trials have …

Aims To assess the impact of the introduction of direct oral anticoagulants upon the
outcomes from elective electrical cardioversion for atrial fibrillation. Methods This is a …

Electrical cardioversion (ECV) can improve quality of life in symptomatic patients with atrial
fibrillation (AF). Resumption of sinus rhythm is associated with an increased risk of …

Background Cardioversion is common among patients with atrial fibrillation (AF). We
hypothesised that novel oral anticoagulants (NOAC) used in clinical practice resulted in …

Introduction Atrial fibrillation (AF) is associated with an increased risk of thromboembolic
events. Objectives This study compared the long-term efficacy and safety of apixaban with …

Background Current guidelines recommend anticoagulation prior to cardioversion in
patients with atrial fibrillation of> 48 h or unknown duration to reduce thromboembolic risk …